Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell, 2006, 126(4):663-676.
[2]
Maherali N, Sridharan R, Xie W, et al. Directly reprogrammed fibroblasts show global epigenetic remodeling and widespread tissue contribution. Cell stem cell, 2007, 1(1):55-70.
[3]
Hanna J, Wernig M, Markoulaki S, et al. Treatment of sickle cell anemia mouse model with iPS cells generated from autologous skin. Science, 2007, 318(5858):1920-1923.
[4]
Meissner A, Wernig M, Jaenisch R. Direct reprogramming of genetically unmodified fibroblasts into pluripotent stem cells. Nat Biotechnol, 2007, 25(10):1177-1181.
[6]
Yamanaka S. Strategies and new developments in the generation of patient-specific pluripotent stem cells. Cell Stem Cell, 2007, 1(1):39-49.
[7]
Takahashi K, Okita K, Nakagawa M, et al. Induction of pluripotent stem cells from fibroblast cultures. Nat Protoc, 2007, 2(12):3081- 3089.
[8]
Takahashi K, Tanabe K, Ohnuki M, et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell, 2007, 131(5):861-872.
[9]
Masaki H, Ishikawa T, Takahashi S, et al. Heterogeneity of pluripotent marker gene expression in colonies generated in human iPS cell induction culture. Stem Cell Res, 2007, (2):105-115.
[11]
Zhao XY, Li W, Lv Z, et al. iPS cells produce viable mice through tetraploid complementation. Nature, 2009, 461(7260):86-90.
[13]
Li H, Li Q, Zuo ZY, et al. Analysis of key factors in the karyotyping of iPS cells from human, rat and pig. Chinese J Cell Biol, 2009, 31(3): 443-447. (in Chinese)
[15]
Guo M, Zeng H, Liu LX, et al. Specific inducement of human induced pluripotency stem cells to neuroepithelial cells. Int J Pathol Clin Med, 2010, 30(2):99-105. (in Chinese)
[16]
Guo M, Zeng H, Liu LX, et al. Specific inducement of human induced pluripotency cells to trophoblast cells. Int J Pathol Clin Med, 2010, 30(2):93-98. (in Chinese)
[17]
Yan X, George T-J Huang, Zhang FM. Cell culture conditions of feeder free for iPS reprogrammed from dental pulp stem cells. Beijing J Stomatology, 2010, 18(3):143-145. (in Chinese)
Wernig M, Meissner A, Foreman R, et al. In vitro reprogramming of fibroblasts into a pluripotent ES-cell-like state. Nature, 2007, 448(7151):318-324.
[10]
Okita K, Ichisaka T, Yamanaka S. Generation of germline-competent induced pluripotent stem cells. Nature, 2007, 448(7151):313-317.
[18]
Sun XY, Liu HL, Fu XB. Dedifferentiation of epidermal cells into transit amplifying cells induced by bFGF. J South Med Univ, 2010, 30(9):2041-2046. (in Chinese)
[19]
Xin XL, Lv CR, Chen DM. Construction of recombinant retroviral vector with bovine Klf4 and establishment of a virus producing cell strain. Acta Vet ET Zootechnica Sinica, 2010, 41(12):1636-1641. (in Chinese)
[21]
Xu J, Wang H, Liang T, et al. In vitro induction of mouse meningeal-derived iPS cells into neural-like cells. Chinese Sci Bull, 2011, 56(8):567-572. (in Chinese)
[22]
Hu XJ, Lai WY, Wan L, et al. Establishment and characterization of induced pluripotent stem cell line from cdyl knockout mice. J Sun Yat-sen Univ (Med Sci), 2011, 32(2):146-154. (in Chinese)
[23]
Du LL, Lin G, Lu GX. Comparison of human induced pluripotent stem cells and Oct4/Nanog gene expression in human embryonic stem cell differentiation. Prog Mod Biomed, 2011, 11(1):1-4. (in Chinese)
[25]
Wernig M, Zhao JP, PruszAK J, et a1. Neurons derived from reprogrammed fibroblasts functionallv integrate into the fetal brain and improve symptoms of rats with Parkinson’s disease. Proc Natl Acad Sci U S A, 2008, 105(15):5856-5861.
[27]
Gore A, Li Z, Fung HL, et al. Somatic coding mutations in human induced pluripotent stem cells. Nature, 2011, 471(7336):63-67.
[28]
Hussein SM, Batada NN, Vuoristo S, et al. Copy number variation and selection during reprogramming to pluripotency. Nature, 2011, 471(7336):58-62.
[30]
Zhao T, Zhang ZN, Rong Z, et al. Immunogenicity of induced pluripotent stem cells. Nature, 2011, 474(7350):212-215.
[24]
Nelson TJ, Martinez-Fernandez A, Yamada S, et a1. Repair of acute myocardial infarction by human sternness factors induced pluripotent stein cells. Circulation, 2009, 120(5):408-416.
[29]
Lister R, Pelizzola M, Kida YS, et al. Hotspots of aberrant epigenomic reprogramming in human induced pluripotent stem cells. Nature, 2011, 471(7336):68-73.